Processa pharmaceuticals to host conference call to discuss 2022 year end results and provide drug development update on march 30, 2023 at 4:30 p.m. est

Hanover, md, march 23, 2023 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) (“processa” or the “company”), a developer of next generation chemotherapy drugs that provide a better safety-efficacy profile than their widely used fda-approved counterparts, today announced that it will host a conference call and live webcast on march 30, 2023 at 4:30 p.m. est to discuss its 2022 results and provide an update on its clinical pipeline for 2023.
PCSA Ratings Summary
PCSA Quant Ranking